Morgan Stanley’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115K Sell
23,180
-24,867
-52% -$121K ﹤0.01% 6100
2025
Q4
$224K Buy
48,047
+6,513
+16% +$29.5K ﹤0.01% 5888
2025
Q3
$198K Buy
41,534
+6,324
+18% +$21.7K ﹤0.01% 5897
2025
Q2
$109K Sell
35,210
-926
-3% -$2.76K ﹤0.01% 6093
2025
Q1
$120K Sell
36,136
-965
-3% -$3.39K ﹤0.01% 5931
2024
Q4
$114K Sell
37,101
-10,095
-21% -$34.4K ﹤0.01% 6008
2024
Q3
$172K Sell
47,196
-12,881
-21% -$52.3K ﹤0.01% 5803
2024
Q2
$275K Buy
60,077
+13,530
+29% +$66K ﹤0.01% 5541
2024
Q1
$229K Sell
46,547
-45,563
-49% -$220K ﹤0.01% 5687
2023
Q4
$434K Buy
92,110
+43,859
+91% +$164K ﹤0.01% 5675
2023
Q3
$123K Buy
48,251
+13,712
+40% +$43.5K ﹤0.01% 5789
2023
Q2
$155K Buy
34,539
+60
+0.2% +$271 ﹤0.01% 5756
2023
Q1
$171K Buy
34,479
+14,550
+73% +$47.1K ﹤0.01% 5780
2022
Q4
$41.1K Sell
19,929
-424,093
-96% -$952K ﹤0.01% 6376
2022
Q3
$1.17M Buy
444,022
+413,267
+1,344% +$1.45M ﹤0.01% 4794
2022
Q2
$111K Buy
30,755
+8,427
+38% +$42.7K ﹤0.01% 6220
2022
Q1
$173K Buy
22,328
+4,534
+25% +$50.9K ﹤0.01% 5999
2021
Q4
$251K Sell
17,794
-84,475
-83% -$1.25M ﹤0.01% 5945
2021
Q3
$1.79M Buy
+102,269
New +$1.8M ﹤0.01% 4657

Other funds holding SOPH